Medy-Tox Inc. (KOSDAQ:086900)
South Korea flag South Korea · Delayed Price · Currency is KRW
119,800
+300 (0.25%)
Aug 29, 2025, 9:39 AM KST

Medy-Tox Revenue

Medy-Tox had revenue of 61.65B KRW in the quarter ending June 30, 2025, a decrease of -5.17%. This brings the company's revenue in the last twelve months to 234.63B, down -4.72% year-over-year. In the year 2024, Medy-Tox had annual revenue of 228.62B with 3.39% growth.

Revenue (ttm)
234.63B
Revenue Growth
-4.72%
P/S Ratio
3.58
Revenue / Employee
332.81M
Employees
724
Market Cap
838.82B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024228.62B7.50B3.39%
Dec 31, 2023221.12B26.02B13.34%
Dec 31, 2022195.10B10.23B5.53%
Dec 31, 2021184.87B44.04B31.27%
Dec 31, 2020140.83B-65.07B-31.60%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Samsung Biologics5,031.69B
Celltrion3,748.95B
ALTEOGEN158.06B
Yuhan2,165.44B
SK Biopharmaceuticals620.28B
PharmaResearch392.31B
Peptron4.30B
LigaChem Biosciences146.42B
Revenue Rankings